Benzinga | Mar 9, 2021 04:06PM EST

Eiger BioPharmaceuticals Q4 EPS $(0.58) Up From $(0.69) YoY

Eiger BioPharmaceuticals (NASDAQ:EIGR) reported quarterly losses of $(0.58) per share. This is a 15.94 percent increase over losses of $(0.69) per share from the same period last year.